Status: Recruiting
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
A study to evaluate the safety and preliminary efficacy of iMSC in subjects with SR-aGVHD
Participants needed: 12
Trial details
Age: 4-70Biological sex: AllType: InterventionalSponsor: Anhui Provincial HospitalUpdated: Mar 27, 2026Locations: 1
Eligibility criteria
Accepted systemic or local treatment of mesenchymal stem cells; [+16]